Works by Soo Yoon Sung

Results: 271
    1

    Pathologic Staging Inconsistency Between ypT4N0 (stage II) and ypT1-2N1 (stage III) After Preoperative Chemoradiotherapy and Total Mesorectal Excision in Rectal Cancer: A Multi-Institutional Study.

    Published in:
    2019
    By:
    • Joo Hwan Lee;
    • Mina Yu;
    • Sung Hwan Kim;
    • Jong Hoon Lee;
    • Soo-Yoon Sung;
    • Bae Kwon Jeong;
    • Songmi Jeong;
    • Taek Keun Nam;
    • Jae Uk Jeong;
    • Hong Seok Jang;
    • Lee, Joo Hwan;
    • Yu, Mina;
    • Kim, Sung Hwan;
    • Lee, Jong Hoon;
    • Sung, Soo-Yoon;
    • Jeong, Bae Kwon;
    • Jeong, Songmi;
    • Nam, Taek Keun;
    • Jeong, Jae Uk;
    • Jang, Hong Seok
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7

    Thrombocytopenic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor in a Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) (MOMENTUM).

    Published in:
    Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 388
    By:
    • Gerds, Aaron;
    • Verstovsek, Srdan;
    • Vannucchi, Alessandro;
    • Al-Ali, Haifa Kathrin;
    • Lavie, David;
    • Kuykendall, Andrew;
    • Grosicki, Sebastian;
    • Iurlo, Alessandra;
    • Goh, Yeow Tee;
    • Lazaroiu, Mihaela;
    • Egyed, Miklos;
    • Fox, Maria Laura;
    • McLornan, Donal;
    • Perkins, Andrew;
    • Sung-Soo Yoon;
    • Gupta, Vikas;
    • Kiladjian, Jean-Jacques;
    • Donahue, Rafe;
    • Kawashima, Jun;
    • Mesa, Ruben
    Publication type:
    Article
    8

    MOMENTUM: Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor.

    Published in:
    Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 377
    By:
    • Mesa, Ruben;
    • Gerds, Aaron;
    • Vannucchi, Alessandro;
    • Al-Ali, Haifa Kathrin;
    • Lavie, David;
    • Kuykendall, Andrew;
    • Grosicki, Sebastian;
    • Iurlo, Alessandra;
    • Yeow Tee Goh;
    • Lazaroiu, Mihaela;
    • Egyed, Miklos;
    • Fox, Maria Laura;
    • McLornan, Donal;
    • Perkins, Andrew;
    • Sung-Soo Yoon;
    • Gupta, Vikas;
    • Kiladjian, Jean-Jacques;
    • Donahue, Rafe;
    • Kawashima, Jun;
    • Verstovsek, Srdan
    Publication type:
    Article
    9
    10

    Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study.

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1355, doi. 10.4143/crt.2023.271
    By:
    • Yu Ri Kim;
    • Jin Seok Kim;
    • Won Seog Kim;
    • Hyeon Seok Eom;
    • Deok-Hwan Yang;
    • Sung Hwa Bae;
    • Hyo Jung Kim;
    • Jae Hoon Lee;
    • Suk-Joong Oh;
    • Sung-Soo Yoon;
    • Jae-Yong Kwak;
    • Chul Won Choi;
    • Min Kyoung Kim;
    • Sung Young Oh;
    • Hye Jin Kang;
    • Seung Hyun Nam;
    • Hyeok Shim;
    • Joon Seong Park;
    • Yeung-Chul Mun;
    • Cheolwon Suh
    Publication type:
    Article
    11
    12
    13

    Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404).

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 2, p. 684, doi. 10.4143/crt.2022.1434
    By:
    • Hyungwoo Cho;
    • Dok Hyun Yoon;
    • Dong-Yeop Shin;
    • Youngil Koh;
    • Sung-Soo Yoon;
    • Seok Jin Kim;
    • Young Rok Do;
    • Gyeong-Won Lee;
    • Jae-Yong Kwak;
    • Yong Park;
    • Min Kyoung Kim;
    • Hye Jin Kang;
    • Jun Ho Yi;
    • Kwai Han Yoo;
    • Won Sik Lee;
    • Byeong Bae Park;
    • Jae Cheol Jo;
    • Hyeon-Seok Eom;
    • Hyo Jung Kim;
    • Seong Hyun Jeong
    Publication type:
    Article
    14
    15
    16
    17
    18

    Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-47198-4
    By:
    • Changhee Park;
    • Ho Sup Lee;
    • Ka-Won Kang;
    • Won-Sik Lee;
    • Young Rok Do;
    • Jae-Yong Kwak;
    • Ho-Jin Shin;
    • Sung-Yong Kim;
    • Jun Ho Yi;
    • Sung-Nam Lim;
    • Jeong-Ok Lee;
    • Deok-Hwan Yang;
    • Hun Jang;
    • Byoungsan Choi;
    • Jiwoo Lim;
    • Choong Hyun Sun;
    • Ja Min Byun;
    • Sung-Soo Yoon;
    • Youngil Koh
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00868-w
    By:
    • Baek, Dong Won;
    • Moon, Joon Ho;
    • Lee, Jae Hoon;
    • Kang, Ka-Won;
    • Lee, Ho Sup;
    • Eom, Hyeon-Seok;
    • Lee, Enuyoung;
    • Lee, Ji Hyun;
    • Lee, Jeong-Ok;
    • Park, Seong Kyu;
    • Kim, Seok Jin;
    • Yoo, Keon Hee;
    • Yoon, Sung-Soo;
    • Koh, Youngil;
    • Kang, Hyoung Jin;
    • Won, Jong-Ho;
    • Lyu, Chuhl Joo;
    • Hahn, Seung Min;
    • Lee, Jung-Hee;
    • Park, Joon Seong
    Publication type:
    Article
    33

    Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00868-w
    By:
    • Baek, Dong Won;
    • Moon, Joon Ho;
    • Lee, Jae Hoon;
    • Kang, Ka-Won;
    • Lee, Ho Sup;
    • Eom, Hyeon-Seok;
    • Lee, Enuyoung;
    • Lee, Ji Hyun;
    • Lee, Jeong-Ok;
    • Park, Seong Kyu;
    • Kim, Seok Jin;
    • Yoo, Keon Hee;
    • Yoon, Sung-Soo;
    • Koh, Youngil;
    • Kang, Hyoung Jin;
    • Won, Jong-Ho;
    • Lyu, Chuhl Joo;
    • Hahn, Seung Min;
    • Lee, Jung-Hee;
    • Park, Joon Seong
    Publication type:
    Article
    34

    Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)—a trial by the Asian Myeloma Network.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 10, p. N.PAG, doi. 10.1038/s41408-019-0245-1
    By:
    • Soekojo, Cinnie Yentia;
    • Kim, Kihyun;
    • Huang, Shang-Yi;
    • Chim, Chor-Sang;
    • Takezako, Naoki;
    • Asaoku, Hideki;
    • Kimura, Hideo;
    • Kosugi, Hiroshi;
    • Sakamoto, Junichi;
    • Gopalakrishnan, Sathish Kumar;
    • Nagarajan, Chandramouli;
    • Wei, Yuan;
    • Moorakonda, Rajesh;
    • Lee, Shu Ling;
    • Lee, Je Jung;
    • Yoon, Sung-Soo;
    • Kim, Jin Seok;
    • Min, Chang Ki;
    • Lee, Jae-Hoon;
    • Durie, Brian
    Publication type:
    Article
    35
    36
    37
    38
    39
    40

    Efficacy and safety of weekly carfilzomib (70 mg/m<sup>2</sup>), dexamethasone, and daratumumab (KdD70) is comparable to twice-weekly KdD56 while being a more convenient dosing option: a cross-study comparison of the CANDOR and EQUULEUS studies.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 2, p. 358, doi. 10.1080/10428194.2020.1832672
    By:
    • Leleu, Xavier;
    • Beksac, Meral;
    • Chou, Takaaki;
    • Dimopoulos, Meletios;
    • Yoon, Sung-Soo;
    • Prince, H. Miles;
    • Pour, Ludek;
    • Shelekhova, Tatiana;
    • Chari, Ajai;
    • Khurana, Monica;
    • Zhang, Jianqi;
    • Obreja, Mihaela;
    • Qi, Ming;
    • Oriol, Albert;
    • Siegel, David
    Publication type:
    Article
    41
    42
    43
    44
    45

    The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma.

    Published in:
    Acta Haematologica, 2018, v. 140, n. 3, p. 146, doi. 10.1159/000490488
    By:
    • Lee, Gyeong-Won;
    • Park, Sung Woo;
    • Go, Se-Il;
    • Kim, Hoon-Gu;
    • Kim, Min Kyoung;
    • Min, Chang-Ki;
    • Kwak, Jae-Yong;
    • Bae, Sang-Byung;
    • Yoon, Sung-Soo;
    • Lee, Je-Jung;
    • Kim, Ki Hwan;
    • Nam, Seung-Hyun;
    • Mun, Yeung-Chul;
    • Kim, Hyo Jung;
    • Bae, Sung Hwa;
    • Shin, Ho-Jin;
    • Lee, Jung-Hee;
    • Park, Joon Seong;
    • Jeong, Seong Hyun;
    • Lee, Mark Hong
    Publication type:
    Article
    46
    47

    RANTES Polymorphisms and the Risk of Graft-versus-Host Disease in Human Leukocyte Antigen-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation.

    Published in:
    Acta Haematologica, 2013, v. 129, n. 3, p. 137, doi. 10.1159/000343273
    By:
    • Shin, Dong-Yeop;
    • Kim, Inho;
    • Kim, Jin Hee;
    • Lee, Yun-Gyoo;
    • Kang, Eun Joo;
    • Cho, Hyeon Jin;
    • Lee, Kyung-Hun;
    • Kim, Hye Jin;
    • Park, Eun-Hee;
    • Lee, Jong-Eun;
    • Bae, Ji-Yeon;
    • See, Cha Ja;
    • Yoon, Sung-Soo;
    • Park, Sung Sup;
    • Han, Kyou-Sup;
    • Park, Myoung Hee;
    • Hong, Yun-Chul;
    • Park, Seonyang;
    • Kim, Byoung Kook
    Publication type:
    Article
    48
    49
    50